IP Library Granted Patent US 9,879,283
Granted Patent B2
US 9,879,283 · App. 14/879,872 · Granted Jan 30, 2018

CRISPR oligonucleotides and gene editing

Inventors: Namritha Ravinder (San Diego, CA); Korbinian Heil (Munich, DE); Yizhu Guo (Castro Valley, CA); Xiquan Liang (Escondido, CA); Robert Potter (San Marcos, CA); Sanjay Kumar (Carlsbad, CA)
Assignees: Life Technologies Corporation; Thermo Fisher Scientific GENEART GmbH
C12N15/907C12N15/102C12N15/11C12P19/34C12Q1/686C12N2310/3519
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,879,283
App. No.
14/879,872
Granted
Jan 30, 2018
Kind
B2
Abstract

The present disclosure generally relates to compositions and methods for the genetic modification of cells. In particular, the disclosure relates to CRISPR reagents and the use of such reagents.

Claims (14)

1. A method for producing a nucleic acid molecule, the method comprising performing polymerase chain reaction (PCR) in a reaction mixture comprising:

(i) a double stranded nucleic acid segment comprising a first terminus and a second terminus,

(ii) a first oligonucleotide comprising a first terminus and a second terminus, wherein the second terminus of the first oligonucleotide is capable of hybridizing to the first terminus of the double stranded nucleic acid segment, and

(iii) a second oligonucleotide comprising a first terminus and a second terminus,

wherein the second terminus of the second oligonucleotide is capable of hybridizing to the first terminus of the first oligonucleotide, to produce the nucleic acid molecule, wherein the product nucleic acid molecule contains a promoter suitable for in vitro transcription at or near one terminus and encodes a CRISPR RNA, and

wherein the reaction mixture further comprises a first primer and a second primer, wherein the first primer is capable of hybridizing at or near the first terminus of the second oligonucleotide and the second primer is capable of hybridizing at or near the second terminus of the double stranded nucleic acid segment.

2. The method of claim 1 , wherein the CRISPR RNA is a guide RNA.

3. The method of claim 2 , wherein the nucleic acid molecule produced by the PCR reaction is from 70 to 150 base pairs in length.

4. The method of claim 1 , wherein the CRISPR RNA is from 35 to 150 nucleotides in length.

5. The method of claim 1 , wherein the CRISPR RNA has at least two hairpin turns.

6. The method of claim 1 , wherein the CRISPR RNA is a crRNA.

7. The method of claim 1 , wherein the CRISPR RNA is a tracrRNA.

8. The method of claim 1 , wherein the promoter is a T7, T3 or SP6 promoter.

9. The method of claim 1 , wherein the first oligonucleotide or the second oligonucleotide is between 35 and 40 nucleotides in length.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 6, 2017
From: KUMAR, SANJAY
To: LIFE TECHNOLOGIES CORPORATION
Reel/Frame 044314/0883 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 28, 2015
From: HEIL, KORBINIAN
To: THERMO FISHER SCIENTIFIC GENEART GMBH
Reel/Frame 037368/0543 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 28, 2015
From: RAVINDER, NAMRITHA; GUO, YIZHU; LIANG, XIQUAN; POTTER, ROBERT
To: LIFE TECHNOLOGIES CORPORATION
Reel/Frame 037368/0732 →
Continuity (4)
Provisional Application 62061961 · Oct 9, 2014
Provisional Application 62101787 · Jan 9, 2015
Provisional Application 62218826 · Sep 15, 2015
Related Publication 20160102322A1 · Apr 14, 2016